Cargando…

Histological Validation of measurement of diffuse interstitial myocardial fibrosis by myocardial extravascular volume fraction from Modified Look-Locker imaging (MOLLI) T1 mapping at 3 T

BACKGROUND: Gadolinium (Gd) Extracellular volume fraction (ECV) by Cardiovascular Magnetic Resonance (CMR) has been proposed as a non-invasive method for assessment of diffuse myocardial fibrosis. Yet only few studies used 3 T CMR to measure ECV, and the accuracy of ECV measurements at 3 T has not b...

Descripción completa

Detalles Bibliográficos
Autores principales: de Meester de Ravenstein, Christophe, Bouzin, Caroline, Lazam, Siham, Boulif, Jamila, Amzulescu, Mihaela, Melchior, Julie, Pasquet, Agnès, Vancraeynest, David, Pouleur, Anne-Catherine, Vanoverschelde, Jean-Louis J., Gerber, Bernhard L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4464705/
https://www.ncbi.nlm.nih.gov/pubmed/26062931
http://dx.doi.org/10.1186/s12968-015-0150-0
_version_ 1782376024492736512
author de Meester de Ravenstein, Christophe
Bouzin, Caroline
Lazam, Siham
Boulif, Jamila
Amzulescu, Mihaela
Melchior, Julie
Pasquet, Agnès
Vancraeynest, David
Pouleur, Anne-Catherine
Vanoverschelde, Jean-Louis J.
Gerber, Bernhard L.
author_facet de Meester de Ravenstein, Christophe
Bouzin, Caroline
Lazam, Siham
Boulif, Jamila
Amzulescu, Mihaela
Melchior, Julie
Pasquet, Agnès
Vancraeynest, David
Pouleur, Anne-Catherine
Vanoverschelde, Jean-Louis J.
Gerber, Bernhard L.
author_sort de Meester de Ravenstein, Christophe
collection PubMed
description BACKGROUND: Gadolinium (Gd) Extracellular volume fraction (ECV) by Cardiovascular Magnetic Resonance (CMR) has been proposed as a non-invasive method for assessment of diffuse myocardial fibrosis. Yet only few studies used 3 T CMR to measure ECV, and the accuracy of ECV measurements at 3 T has not been established. Therefore the aims of the present study were to validate measurement of ECV by MOLLI T1 mapping by 3 T CMR against fibrosis measured by histopathology. We also evaluated the recently proposed hypothesis that native-T1 mapping without contrast injection would be sufficient to detect fibrosis. METHODS: 31 patients (age = 58 ± 17 years, 77 % men) with either severe aortic stenosis (n = 12) severe aortic regurgitation (n = 9) or severe mitral regurgitation (n = 10), all free of coronary artery disease, underwent 3 T-CMR with late gadolinium enhancement (LGE) and pre- and post-contrast MOLLI T1 mapping and ECV computation, prior to valve surgery. LV biopsies were performed at the time of surgery, a median 13 [1–30] days later, and stained with picrosirius red. Pre-, and post-contrast T1 values, ECV, and amount of LGE were compared against magnitude of fibrosis by histopathology by Pearson correlation coefficients. RESULTS: The average amount of interstitial fibrosis by picrosirius red staining in biopsy samples was 6.1 ± 4.3 %. ECV computed from pre-post contrast MOLLI T1 time changes was 28.9 ± 5.5 %, and correlated (r = 0.78, p < 0.001) strongly with the magnitude of histological fibrosis. By opposition, neither amount of LGE (r = 0.17, p = 0.36) nor native pre-contrast myocardial T1 time (r = −0.18, p = 0.32) correlated with fibrosis by histopathology. CONCLUSIONS: ECV determined by 3 T CMR T1 MOLLI images closely correlates with histologically determined diffuse interstitial fibrosis, providing a non-invasive estimation for quantification of interstitial fibrosis in patients with valve diseases. By opposition, neither non-contrast T1 times nor the amount of LGE were indicative of the magnitude of diffuse interstitial fibrosis measured by histopathology.
format Online
Article
Text
id pubmed-4464705
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-44647052015-06-29 Histological Validation of measurement of diffuse interstitial myocardial fibrosis by myocardial extravascular volume fraction from Modified Look-Locker imaging (MOLLI) T1 mapping at 3 T de Meester de Ravenstein, Christophe Bouzin, Caroline Lazam, Siham Boulif, Jamila Amzulescu, Mihaela Melchior, Julie Pasquet, Agnès Vancraeynest, David Pouleur, Anne-Catherine Vanoverschelde, Jean-Louis J. Gerber, Bernhard L. J Cardiovasc Magn Reson Research BACKGROUND: Gadolinium (Gd) Extracellular volume fraction (ECV) by Cardiovascular Magnetic Resonance (CMR) has been proposed as a non-invasive method for assessment of diffuse myocardial fibrosis. Yet only few studies used 3 T CMR to measure ECV, and the accuracy of ECV measurements at 3 T has not been established. Therefore the aims of the present study were to validate measurement of ECV by MOLLI T1 mapping by 3 T CMR against fibrosis measured by histopathology. We also evaluated the recently proposed hypothesis that native-T1 mapping without contrast injection would be sufficient to detect fibrosis. METHODS: 31 patients (age = 58 ± 17 years, 77 % men) with either severe aortic stenosis (n = 12) severe aortic regurgitation (n = 9) or severe mitral regurgitation (n = 10), all free of coronary artery disease, underwent 3 T-CMR with late gadolinium enhancement (LGE) and pre- and post-contrast MOLLI T1 mapping and ECV computation, prior to valve surgery. LV biopsies were performed at the time of surgery, a median 13 [1–30] days later, and stained with picrosirius red. Pre-, and post-contrast T1 values, ECV, and amount of LGE were compared against magnitude of fibrosis by histopathology by Pearson correlation coefficients. RESULTS: The average amount of interstitial fibrosis by picrosirius red staining in biopsy samples was 6.1 ± 4.3 %. ECV computed from pre-post contrast MOLLI T1 time changes was 28.9 ± 5.5 %, and correlated (r = 0.78, p < 0.001) strongly with the magnitude of histological fibrosis. By opposition, neither amount of LGE (r = 0.17, p = 0.36) nor native pre-contrast myocardial T1 time (r = −0.18, p = 0.32) correlated with fibrosis by histopathology. CONCLUSIONS: ECV determined by 3 T CMR T1 MOLLI images closely correlates with histologically determined diffuse interstitial fibrosis, providing a non-invasive estimation for quantification of interstitial fibrosis in patients with valve diseases. By opposition, neither non-contrast T1 times nor the amount of LGE were indicative of the magnitude of diffuse interstitial fibrosis measured by histopathology. BioMed Central 2015-06-11 /pmc/articles/PMC4464705/ /pubmed/26062931 http://dx.doi.org/10.1186/s12968-015-0150-0 Text en © De Meester de Ravenstein et al.; licensee BioMed Central. 2015 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
de Meester de Ravenstein, Christophe
Bouzin, Caroline
Lazam, Siham
Boulif, Jamila
Amzulescu, Mihaela
Melchior, Julie
Pasquet, Agnès
Vancraeynest, David
Pouleur, Anne-Catherine
Vanoverschelde, Jean-Louis J.
Gerber, Bernhard L.
Histological Validation of measurement of diffuse interstitial myocardial fibrosis by myocardial extravascular volume fraction from Modified Look-Locker imaging (MOLLI) T1 mapping at 3 T
title Histological Validation of measurement of diffuse interstitial myocardial fibrosis by myocardial extravascular volume fraction from Modified Look-Locker imaging (MOLLI) T1 mapping at 3 T
title_full Histological Validation of measurement of diffuse interstitial myocardial fibrosis by myocardial extravascular volume fraction from Modified Look-Locker imaging (MOLLI) T1 mapping at 3 T
title_fullStr Histological Validation of measurement of diffuse interstitial myocardial fibrosis by myocardial extravascular volume fraction from Modified Look-Locker imaging (MOLLI) T1 mapping at 3 T
title_full_unstemmed Histological Validation of measurement of diffuse interstitial myocardial fibrosis by myocardial extravascular volume fraction from Modified Look-Locker imaging (MOLLI) T1 mapping at 3 T
title_short Histological Validation of measurement of diffuse interstitial myocardial fibrosis by myocardial extravascular volume fraction from Modified Look-Locker imaging (MOLLI) T1 mapping at 3 T
title_sort histological validation of measurement of diffuse interstitial myocardial fibrosis by myocardial extravascular volume fraction from modified look-locker imaging (molli) t1 mapping at 3 t
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4464705/
https://www.ncbi.nlm.nih.gov/pubmed/26062931
http://dx.doi.org/10.1186/s12968-015-0150-0
work_keys_str_mv AT demeesterderavensteinchristophe histologicalvalidationofmeasurementofdiffuseinterstitialmyocardialfibrosisbymyocardialextravascularvolumefractionfrommodifiedlooklockerimagingmollit1mappingat3t
AT bouzincaroline histologicalvalidationofmeasurementofdiffuseinterstitialmyocardialfibrosisbymyocardialextravascularvolumefractionfrommodifiedlooklockerimagingmollit1mappingat3t
AT lazamsiham histologicalvalidationofmeasurementofdiffuseinterstitialmyocardialfibrosisbymyocardialextravascularvolumefractionfrommodifiedlooklockerimagingmollit1mappingat3t
AT boulifjamila histologicalvalidationofmeasurementofdiffuseinterstitialmyocardialfibrosisbymyocardialextravascularvolumefractionfrommodifiedlooklockerimagingmollit1mappingat3t
AT amzulescumihaela histologicalvalidationofmeasurementofdiffuseinterstitialmyocardialfibrosisbymyocardialextravascularvolumefractionfrommodifiedlooklockerimagingmollit1mappingat3t
AT melchiorjulie histologicalvalidationofmeasurementofdiffuseinterstitialmyocardialfibrosisbymyocardialextravascularvolumefractionfrommodifiedlooklockerimagingmollit1mappingat3t
AT pasquetagnes histologicalvalidationofmeasurementofdiffuseinterstitialmyocardialfibrosisbymyocardialextravascularvolumefractionfrommodifiedlooklockerimagingmollit1mappingat3t
AT vancraeynestdavid histologicalvalidationofmeasurementofdiffuseinterstitialmyocardialfibrosisbymyocardialextravascularvolumefractionfrommodifiedlooklockerimagingmollit1mappingat3t
AT pouleurannecatherine histologicalvalidationofmeasurementofdiffuseinterstitialmyocardialfibrosisbymyocardialextravascularvolumefractionfrommodifiedlooklockerimagingmollit1mappingat3t
AT vanoverscheldejeanlouisj histologicalvalidationofmeasurementofdiffuseinterstitialmyocardialfibrosisbymyocardialextravascularvolumefractionfrommodifiedlooklockerimagingmollit1mappingat3t
AT gerberbernhardl histologicalvalidationofmeasurementofdiffuseinterstitialmyocardialfibrosisbymyocardialextravascularvolumefractionfrommodifiedlooklockerimagingmollit1mappingat3t